A detailed history of Td Private Client Wealth LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Td Private Client Wealth LLC holds 12,543 shares of LLY stock, worth $9.96 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
12,543
Previous 11,874 5.63%
Holding current value
$9.96 Million
Previous $10.8 Billion 3.37%
% of portfolio
0.32%
Previous 0.34%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$772.14 - $960.02 $516,561 - $642,253
669 Added 5.63%
12,543 $11.1 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $8.61 Million - $10.8 Million
11,874 New
11,874 $10.8 Billion
Q1 2024

Aug 16, 2024

BUY
$592.2 - $792.28 $649,051 - $868,338
1,096 Added 7.0%
16,744 $13 Billion
Q4 2023

Aug 16, 2024

SELL
$525.19 - $619.13 $652,811 - $769,578
-1,243 Reduced 7.36%
15,648 $9.12 Billion
Q3 2023

Aug 16, 2024

SELL
$434.7 - $599.3 $406,879 - $560,944
-936 Reduced 5.25%
16,891 $9.07 Billion
Q2 2023

Aug 16, 2024

BUY
$350.74 - $468.98 $1.69 Million - $2.26 Million
4,828 Added 37.14%
17,827 $8.36 Billion
Q1 2023

Aug 16, 2024

BUY
$310.63 - $364.82 $7,765 - $9,120
25 Added 0.19%
12,999 $4.46 Billion
Q4 2022

Aug 16, 2024

BUY
$321.55 - $374.67 $404,831 - $471,709
1,259 Added 10.75%
12,974 $4.75 Billion
Q3 2022

Aug 16, 2024

SELL
$296.48 - $337.87 $547,895 - $624,383
-1,848 Reduced 13.63%
11,715 $3.79 Billion
Q2 2022

Aug 16, 2024

SELL
$278.73 - $327.27 $97,276 - $114,217
-349 Reduced 2.51%
13,563 $4.4 Billion
Q1 2022

Aug 16, 2024

SELL
$234.69 - $291.66 $207,700 - $258,119
-885 Reduced 5.98%
13,912 $3.98 Billion
Q4 2021

Aug 16, 2024

BUY
$224.85 - $279.04 $2.22 Million - $2.76 Million
9,876 Added 200.69%
14,797 $4.09 Billion
Q3 2021

Aug 16, 2024

SELL
$221.6 - $272.71 $1.54 Million - $1.9 Million
-6,953 Reduced 58.56%
4,921 $1.14 Billion
Q2 2021

Aug 16, 2024

SELL
$180.55 - $233.54 $39,901 - $51,612
-221 Reduced 4.17%
5,079 $1.17 Billion
Q1 2021

Aug 16, 2024

SELL
$164.32 - $212.72 $30,070 - $38,927
-183 Reduced 3.34%
5,300 $990 Million
Q4 2020

Aug 16, 2024

SELL
$130.46 - $172.63 $2 Million - $2.65 Million
-15,364 Reduced 73.7%
5,483 $926 Million
Q3 2020

Aug 16, 2024

SELL
$146.22 - $169.13 $119,461 - $138,179
-817 Reduced 3.77%
20,847 $3.09 Billion
Q2 2020

Aug 16, 2024

BUY
$136.42 - $164.18 $432,997 - $521,107
3,174 Added 17.17%
21,664 $3.56 Billion
Q1 2020

Aug 16, 2024

BUY
$119.05 - $147.35 $211,075 - $261,251
1,773 Added 10.61%
18,490 $2.56 Billion
Q4 2019

Aug 16, 2024

BUY
$106.92 - $132.43 $517,813 - $641,358
4,843 Added 40.79%
16,717 $2.2 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.